Silver Lining: Reduced Relapse with Chronic GVHD after Transplant for MDS.
retrospective_cohort · Level III
Where this comes from
- Record sourced from PubMed, PMID 33067257.
- Also identified by DOI 10.1158/1078-0432.CCR-20-3583.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Chronic GVHD following hematopoietic cell transplantation is associated with reduced relapse incidence in patients with leukemias. This impact has been investigated in myelodysplastic syndrome, showing a beneficial impact of limited chronic GVHD on transplant outcomes in a cohort of more than 3,000 patients.<i>See related article by Konuma et al., p. 6483</i>.
Medical subject headings
- Graft vs Host Disease
- Hematopoietic Stem Cell Transplantation
- Myelodysplastic Syndromes